StockData
IMMUTEP Ltd logo

IMMUTEP Ltd (IMMP) stock

IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 23, 2026Score 8/30
$3.48−0.17 (-4.79%)

Close on Nov 13, 2026Market cap $25.64MP/E –Yield –

Immutep total assets

Total assets on the balance sheet at the end of each period.

Immutep's total assets was A$83.27M at Jun 30, 2026. For fiscal 2026 it was A$83.27M, down 47.0% from the year before. Over ten years it grew 6.9% a year on average. The highest annual figure on record is A$201.58M in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2026Jun 30, 2026A$83.27M-47.0%
FY2025Jun 30, 2025A$156.98M-22.1%
FY2024Jun 30, 2024A$201.58M+36.7%
FY2023Jun 30, 2023A$147.45M+44.3%
FY2022Jun 30, 2022A$102.17M+24.6%
FY2021Jun 30, 2021A$82.03M+76.0%
FY2020Jun 30, 2020A$46.60M+14.9%
FY2019Jun 30, 2019A$40.54M-13.7%
FY2018Jun 30, 2018A$47.00M+34.4%
FY2017Jun 30, 2017A$34.96M-17.8%
FY2016Jun 30, 2016A$42.55M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026A$83.27M-18.5%
Q4 FY2025CQ2 2025Jun 30, 2025A$156.98M+91.4%
Q4 FY2024CQ2 2024Jun 30, 2024A$201.58M+332.6%
Q4 FY2023CQ2 2023Jun 30, 2023A$147.45M+263.7%
Q4 FY2022CQ2 2022Jun 30, 2022A$102.17M+117.4%
Q4 FY2021CQ2 2021Jun 30, 2021A$82.03M+134.6%
Q4 FY2020CQ2 2020Jun 30, 2020A$46.60M+9.5%
Q4 FY2019CQ2 2019Jun 30, 2019A$40.54M–
Q4 FY2018CQ2 2018Jun 30, 2018A$47.00M–
Q4 FY2017CQ2 2017Jun 30, 2017A$34.96M–
Q4 FY2016CQ2 2016Jun 30, 2016A$42.55M–

More Immutep figures

See a number that looks wrong?